Nemus Bioscience (OTCMKTS:NMUS) Share Price Crosses Above Fifty Day Moving Average – What’s Next?

Nemus Bioscience Inc (OTCMKTS:NMUS – Get Free Report)’s share price passed above its fifty day moving average during trading on Monday . The stock has a fifty day moving average of $0.76 and traded as high as $0.87. Nemus Bioscience shares last traded at $0.8136, with a volume of 197,253 shares traded.

Nemus Bioscience Price Performance

The stock has a market cap of $108.95 million, a price-to-earnings ratio of -9.04 and a beta of -0.04. The company’s 50 day simple moving average is $0.76.

About Nemus Bioscience

(Get Free Report)

Nemus Bioscience, Inc is an early‐stage biopharmaceutical company developing proprietary prodrug cannabinoid therapeutics for ophthalmic, dermatological and metabolic diseases. The company leverages synthetic derivatives of naturally occurring cannabinoids, designed to improve bioavailability, tissue targeting and therapeutic efficacy. Nemus operates under an OTCMKTS listing and is headquartered in Houston, Texas.

The company’s pipeline includes multiple preclinical candidates, with lead programs focusing on ophthalmic and dermatological indications.

Featured Articles

• Five stocks we like better than Nemus Bioscience
• Why Applied Optoelectronics Stock May Be Near a Turning Point
• From High-Yield to High-Growth: 3 Stocks Boosting Dividends
• Is Everspin Technologies the Next AI Edge Breakout?
• 5 Robotics Stocks to Watch as Physical AI Builds Momentum